TY - JOUR
T1 - Risk of sequelae after chlamydia trachomatis genital infection in women
AU - Haggerty, Catherine L.
AU - Gottlieb, Sami L.
AU - Taylor, Brandie D.
AU - Low, Nicola
AU - Xu, Fujie
AU - Ness, Roberta B.
N1 - Funding Information:
Potential conflicts of interest: None reported. Financial support: None reported. Supplement sponsorship: This article is part of a supplement entitled “Chlamydia trachomatis Genital Infection: Natural History, Immunobiology, and Implications for Control Programs,” which was sponsored by the Centers for Disease Control and Prevention. Reprints or correspondence: Dr Catherine L. Haggerty, University of Pittsburgh, Dept of Epidemiology, 130 DeSoto St, 516B Parran Hall, Pittsburgh, PA 15261 ([email protected]).
PY - 2010/6/15
Y1 - 2010/6/15
N2 - Chlamydia trachomatis infection, the most common reportable disease in the United States, can lead to pelvic inflammatory disease (FID), infertility, ectopic pregnancy, and chronic pelvic pain. Although C. trachomatis is identified among many women who receive a diagnosis of PID, the incidence and timing of PID and longterm sequelae from an untreated chlamydial infection have not been fully determined. This article examines evidence reviewed as part of the Centers for Disease Control and Prevention Chlamydia Immunology and Control Expert Advisory Meeting; 24 reports were included. We found no prospective studies directly assessing risk of long-term reproductive sequelae, such as infertility, after untreated C. trachomatis infection. Several studies assessed PID diagnosis after untreated chlamydial infection, but rates varied widely, making it difficult to determine an overall estimate. In high-risk settings, 2%-5% of untreated women developed PID within the ∼2-week period between testing positive for C. trachomatis and returning for treatment. However, the rate of PID progression in the general, asymptomatic population followed up for longer periods appeared to be low. According to the largest studies, after symptomatic PID of any cause has occurred, up to 18% of women may develop infertility. In several studies, repeated chlamydial infection was associated with PID and other reproductive sequelae, although it was difficult to determine whether the risk per infection increased with each recurrent episode. The present review critically evaluates this body of literature and suggests future research directions. Specifically, prospective studies assessing rates of symptomatic PID, subclinical tubal damage, and long-term reproductive sequelae after C. trachomatis infection; better tools to measure PID and tubal damage; and studies on the natural history of repeated chlamydial infections are needed.
AB - Chlamydia trachomatis infection, the most common reportable disease in the United States, can lead to pelvic inflammatory disease (FID), infertility, ectopic pregnancy, and chronic pelvic pain. Although C. trachomatis is identified among many women who receive a diagnosis of PID, the incidence and timing of PID and longterm sequelae from an untreated chlamydial infection have not been fully determined. This article examines evidence reviewed as part of the Centers for Disease Control and Prevention Chlamydia Immunology and Control Expert Advisory Meeting; 24 reports were included. We found no prospective studies directly assessing risk of long-term reproductive sequelae, such as infertility, after untreated C. trachomatis infection. Several studies assessed PID diagnosis after untreated chlamydial infection, but rates varied widely, making it difficult to determine an overall estimate. In high-risk settings, 2%-5% of untreated women developed PID within the ∼2-week period between testing positive for C. trachomatis and returning for treatment. However, the rate of PID progression in the general, asymptomatic population followed up for longer periods appeared to be low. According to the largest studies, after symptomatic PID of any cause has occurred, up to 18% of women may develop infertility. In several studies, repeated chlamydial infection was associated with PID and other reproductive sequelae, although it was difficult to determine whether the risk per infection increased with each recurrent episode. The present review critically evaluates this body of literature and suggests future research directions. Specifically, prospective studies assessing rates of symptomatic PID, subclinical tubal damage, and long-term reproductive sequelae after C. trachomatis infection; better tools to measure PID and tubal damage; and studies on the natural history of repeated chlamydial infections are needed.
UR - http://www.scopus.com/inward/record.url?scp=77953099410&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953099410&partnerID=8YFLogxK
U2 - 10.1086/652395
DO - 10.1086/652395
M3 - Review article
C2 - 20470050
AN - SCOPUS:77953099410
SN - 0022-1899
VL - 201
SP - S134-S155
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - SUPPL. 2
ER -